Congress quietly expands federal control over AI, biotech, semiconductors

What it does

This bill amends the 1950 Defense Production Act to create a new Subcommittee on Emerging Technology within the Defense Production Act Committee. The Subcommittee will analyze how cutting-edge technologies—including AI, semiconductors, quantum computing, biotech, and space systems—can strengthen national defense and improve supply chains across government and industry. The bill also directs the Subcommittee to study whether the U.S. should establish a strategic reserve of critical biomanufacturing capacity to support defense needs.

Why we flagged it

The bill amends the Defense Production Act of 1950 to establish an Emerging Technology Subcommittee within the Defense Production Act Committee, tasking it with analyzing and coordinating emerging technologies (AI, biotech, semiconductors, quantum computing, etc.) for national defense and supply chain resilience. It is fundamentally a structural and procedural modernization of Cold War-era defense mobilization authority.

What the text implies

• The bill grants broad authority to define 'covered technology' without legislative specificity, potentially allowing the Subcommittee to expand scope beyond the listed fields (AI, biotech, cryptography, semiconductors, space, materials science) to capture adjacent or emerging sectors with minimal congressional oversight.
• Establishing a 'strategic reserve of critical biomanufacturing' may signal intent to stockpile or control production capacity in biotech/pharma sectors under national defense authority, potentially restricting private-sector access or pricing during peacetime.

The full analysis lists 4 implications of this text.

Who stands to gain

semiconductor manufacturers; artificial intelligence companies; biotechnology and biomanufacturing firms